Author:
Wu Xiang-Guang,Zhou Chen-Fei,Zhang Yan-Mei,Yan Rui-Ming,Wei Wen-Fei,Chen Xiao-Jing,Yi Hong-Yan,Liang Luo-Jiao,Fan Liang-sheng,Liang Li,Wu Sha,Wang Wei
Funder
The National Natural Science Foundation of China
The Shenzhen Science and Technology Programme
The National Key Research and Development Program of China
The Natural Science foundation of Guangdong province
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Clinical Biochemistry,Physiology
Reference45 articles.
1. Shrestha AD, Neupane D, Vedsted P, Kallestrup P (2018) Cervical cancer prevalence, incidence and mortality in low and middle income countries: a systematic review. Asian Pac J Cancer Prevent 19(2):319–324
2. Li H, Wu X: Advances in diagnosis and treatment of metastatic cervical cancer. 2016, 27(4):e43
3. Jayson GC, Kerbel R, Ellis LM, Harris AL (2016) Antiangiogenic therapy in oncology: current status and future directions. Lancet 388(10043):518–529
4. Tewari KS, Sill MW, Long HJ, Penson RT, Huang H, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM et al (2014) Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med 370(8):734–743
5. Alldredge JK, Tewari KS (2016) Clinical trials of antiangiogenesis therapy in recurrent/persistent and metastatic cervical cancer. Oncologist 21(5):576–585
Cited by
161 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献